Outcome of patients with recurrent medulloblastoma and ependymoma treated with pembrolizumab, an immune checkpoint inhibitor: A Pediatric Brain Tumor Consortium study (PBTC045) Meeting Abstract
| Authors: | Hwang, E. I.; Kilburn, L. B.; Mitchell, D. A.; Lin, T.; Young-Poussaint, T.; Robinson, G.; Gajjar, A.; Lenzen, A.; Dorris, K.; Robison, N.; Fangusaro, J. R.; Fouladi, M.; Onar-Thomas, A.; Dunkel, I. J. |
| Abstract Title: | Outcome of patients with recurrent medulloblastoma and ependymoma treated with pembrolizumab, an immune checkpoint inhibitor: A Pediatric Brain Tumor Consortium study (PBTC045) |
| Meeting Title: | 21st International Symposium on Pediatric Neuro-Oncology (ISPNO 2024) |
| Journal Title: | Neuro-Oncology |
| Volume: | 26 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2024 Jun 28-July 2 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-06-01 |
| Start Page: | iv111 |
| Language: | English |
| ACCESSION: | WOS:001252720000269 |
| DOI: | 10.1093/neuonc/noae064.379 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: IMMU-08 -- Source: Wos |
